Negative regulation of translational elongation

pathway activity — cross-omics
GO:0045900Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of translational elongation pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SHFL, GPR65, and SLC9A9, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of translational elongation activity versus SHFL in BRCA (Pearson r = 0.29).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCASHFL →+0.557+0.082.002.00234
UCECGPR65 →+0.559+0.110<.001<.00134
BRCASLC9A9 →+0.643+0.105<.001<.00134
BRCAPLSCR1 →+0.927+0.113<.001<.00134
LUADEBI3 →+0.454+0.438.002.00634
LUADMS4A1 →+0.737+0.501.005.00434
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0045900 vs SHFL — BRCA

Per-sample scatter of Negative regulation of translational elongation activity vs SHFL in BRCA.

Explore this scatter interactively →

Exploration